about
Recent advances in understanding Kaposi's sarcoma-associated herpesvirusSirtuins in epigenetic regulationAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesA Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer CellsHistone deacetylase inhibitors in clinical studies as templates for new anticancer agents.Novel sirtuin inhibitory warheads derived from the N(ε)-acetyl-lysine analog L-2-amino-7-carboxamidoheptanoic acid.Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Sirtuins Expression and Their Role in Retinal Diseases.Suppressive effects of sirtinol on human cytomegalovirus (hCMV) infection and hCMV-induced activation of molecular mechanisms of senescence and production of reactive oxygen species.An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3.A Fluorescent Probe for Imaging Sirtuin Activity in Living Cells, Based on One-Step Cleavage of the Dabcyl Quencher.Lessons learned from a SIRT2-selective inhibitorDysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.Cinnamaldehyde, Cinnamic Acid, and Cinnamyl Alcohol, the Bioactives of Cinnamomum cassia Exhibit HDAC8 Inhibitory Activity: An In vitro and In silico Study.SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a.Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.Sirtuins at the crossroads of stemness, aging, and cancer.Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors.SIRT7 Is an RNA-Activated Protein Lysine Deacylase.Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.A Selective Cyclic Peptidic Human SIRT5 Inhibitor.SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression
P2860
Q26751238-2DA1DBC1-300D-446F-8BE2-AF6777CBEF84Q27026861-E2DD3400-AC6E-4ABF-AB1E-4D41293E9D3FQ28074536-399632E0-2571-41C4-9DC8-066708DCF1C2Q28081001-2F20FBB9-FAA5-4D69-80EC-D0247CD2A1CEQ33636551-29509D39-6835-4121-BC15-34129864169CQ35214924-D7212622-D6EF-4750-A294-0B1CC1B40589Q35792091-EA55EDAE-8E93-4A08-B614-213A3B68C42AQ36738761-92F744B2-360B-4F2F-A211-6C017C0D3877Q37114055-4F4E2742-34AC-4891-B7A9-45817B3ED68CQ38833038-BA0DAA5C-EC57-450A-BDFB-1275EE6A395BQ39135669-2B31F783-11D8-4BA8-ADA7-BB3DB062614BQ40834621-73A55A2B-7FED-4145-82D6-B0F09C10844CQ41155454-0D392362-C447-4E85-B1D0-B549DCE07B85Q41672733-A28624D7-B25A-44F6-B895-ED1FDB5294A8Q42393149-C8D91998-73BF-4410-B8C8-D9727838F009Q44176860-B9A7D9E8-8BDD-4455-93F5-CA2EA13C2C00Q47117370-CB77800A-3D82-4E31-B8D6-7197EE6BA62BQ47144786-02A235D6-36D8-4FF4-8533-354A55CB2BB3Q47145765-4F8D9F5A-28C8-4C68-8E4C-34FBEC7B0C6FQ47237639-A81D63DB-A214-45C6-9876-4D2D5AF47813Q47315020-8DB95A21-BCC1-48C1-88A5-C0BDA8AD6557Q48134740-6841CF5C-A05B-485B-8ACE-87119D609AFDQ49887884-893DA28E-2DE2-49F7-8D70-BEFF301482F6Q51509279-9DB6A22F-9C2C-458A-915C-745C0462FFEFQ57490805-EDDAFA63-C46E-40B6-8763-B6F00855ABD9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sirtuin inhibitors as anticancer agents.
@en
type
label
Sirtuin inhibitors as anticancer agents.
@en
prefLabel
Sirtuin inhibitors as anticancer agents.
@en
P2860
P356
P1476
Sirtuin inhibitors as anticancer agents
@en
P2093
P2860
P304
P356
10.4155/FMC.14.44
P50
P577
2014-05-01T00:00:00Z